Orhan Nalcioglu • UCI Profiles (original) (raw)

  1. Feasibility study of a new RF coil design for prostate MRI. Phys Med Biol. 2014 Sep 07; 59(17):N163-9. Ha S, Roeck WW, Cho J, Nalcioglu O. PMID: 25138915.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  2. In vivo validation of quantitative frequency domain fluorescence tomography. J Biomed Opt. 2012 Dec; 17(12):126021. Lin Y, Ghijsen M, Nalcioglu O, Gulsen G. PMID: 23323291; PMCID: PMC3525318.
    View in: PubMed Mentions: 4 Fields:
    Translation:Animals
  3. Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys. 2011 Nov; 38(11):5961-8. Chang DH, Chen JH, Lin M, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang DJ, Nalcioglu O, Su MY. PMID: 22047360; PMCID: PMC3215688.
    View in: PubMed Mentions: 21 Fields:
    Translation:Humans
  4. Aquaporin-4-dependent edema clearance following status epilepticus. Epilepsy Res. 2012 Feb; 98(2-3):264-8. Lee DJ, Amini M, Hamamura MJ, Hsu MS, Seldin MM, Nalcioglu O, Binder DK. PMID: 21996149.
    View in: PubMed Mentions: 16 Fields:
    Translation:Animals
  5. Feasibility study of a unilateral RF array coil for MR-scintimammography. Phys Med Biol. 2011 Nov 07; 56(21):6809-22. Ha S, Hamamura MJ, Roeck WW, Hugg J, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 21971137; PMCID: PMC3517888.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  6. Tumor characterization in small animals using magnetic resonance-guided dynamic contrast enhanced diffuse optical tomography. J Biomed Opt. 2011 Oct; 16(10):106015. Lin Y, Thayer D, Nalcioglu O, Gulsen G. PMID: 22029362; PMCID: PMC3221711.
    View in: PubMed Mentions: 10 Fields:
    Translation:Animals
  7. Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. Radiology. 2011 Dec; 261(3):744-51. Chan S, Su MY, Lei FJ, Wu JP, Lin M, Nalcioglu O, Feig SA, Chen JH. PMID: 21878616; PMCID: PMC3219914.
    View in: PubMed Mentions: 22 Fields:
    Translation:Humans
  8. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. PMID: 21878615; PMCID: PMC3219909.
    View in: PubMed Mentions: 31 Fields:
    Translation:Humans
  9. Spatial shrinkage/expansion patterns between breast density measured in two MRI scans evaluated by non-rigid registration. Phys Med Biol. 2011 Sep 21; 56(18):5865-75. Lin M, Chen JH, Mehta RS, Bahri S, Chan S, Nalcioglu O, Su MY. PMID: 21852724; PMCID: PMC3498815.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  10. Optimal analysis method for dynamic contrast-enhanced diffuse optical tomography. Int J Biomed Imaging. 2011; 2011:426503. Ghijsen M, Lin Y, Hsing M, Nalcioglu O, Gulsen G. PMID: 21811492; PMCID: PMC3147123.
    View in: PubMed Mentions: 2
  11. A photo-multiplier tube-based hybrid MRI and frequency domain fluorescence tomography system for small animal imaging. Phys Med Biol. 2011 Aug 07; 56(15):4731-47. Lin Y, Ghijsen MT, Gao H, Liu N, Nalcioglu O, Gulsen G. PMID: 21753235; PMCID: PMC3961472.
    View in: PubMed Mentions: 15 Fields:
    Translation:Animals
  12. Simultaneous in vivo dynamic contrast-enhanced magnetic resonance and scintigraphic imaging. Phys Med Biol. 2011 Feb 21; 56(4):N63-9. Hamamura MJ, Roeck WW, Ha S, Hugg J, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 21258141.
    View in: PubMed Mentions: 2 Fields:
    Translation:Animals
  13. MR-based keyhole SPECT for small animal imaging. Phys Med Biol. 2011 Feb 07; 56(3):685-702. Lee KS, Roeck WW, Gullberg GT, Nalcioglu O. PMID: 21220840; PMCID: PMC3074940.
    View in: PubMed Mentions: Fields:
    Translation:Animals
  14. A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. Med Phys. 2011 Jan; 38(1):5-14. Lin M, Chan S, Chen JH, Chang D, Nie K, Chen ST, Lin CJ, Shih TC, Nalcioglu O, Su MY. PMID: 21361169; PMCID: PMC3017578.
    View in: PubMed Mentions: 32 Fields:
    Translation:Humans
  15. Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed. 2011 Apr; 24(3):316-24. Chen JH, Mehta RS, Baek HM, Nie K, Liu H, Lin MQ, Yu HJ, Nalcioglu O, Su MY. PMID: 20862660; PMCID: PMC3075960.
    View in: PubMed Mentions: 21 Fields:
    Translation:Humans
  16. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? J Oncol. 2010; 2010. Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. PMID: 20885929; PMCID: PMC2946595.
    View in: PubMed Mentions: 16
  17. Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magn Reson Imaging. 2011 Jan; 29(1):91-8. Chen JH, Chang YC, Chang D, Wang YT, Nie K, Chang RF, Nalcioglu O, Huang CS, Su MY. PMID: 20832226; PMCID: PMC3005955.
    View in: PubMed Mentions: 27 Fields:
    Translation:Humans
  18. Computational simulation of breast compression based on segmented breast and fibroglandular tissues on magnetic resonance images. Phys Med Biol. 2010 Jul 21; 55(14):4153-68. Shih TC, Chen JH, Liu D, Nie K, Sun L, Lin M, Chang D, Nalcioglu O, Su MY. PMID: 20601773; PMCID: PMC2993491.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  19. Quantitative fluorescence tomography using a trimodality system: in vivo validation. J Biomed Opt. 2010 Jul-Aug; 15(4):040503. Lin Y, Barber WC, Iwanczyk JS, Roeck WW, Nalcioglu O, Gulsen G. PMID: 20799770; PMCID: PMC2937044.
    View in: PubMed Mentions: 10 Fields:
    Translation:Animals
  20. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci. 2010 Jun 02; 30(22):7484-94. Dubé CM, Ravizza T, Hamamura M, Zha Q, Keebaugh A, Fok K, Andres AL, Nalcioglu O, Obenaus A, Vezzani A, Baram TZ. PMID: 20519523; PMCID: PMC2906240.
    View in: PubMed Mentions: 130 Fields:
    Translation:Animals
  21. Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys. 2010 Jun; 37(6):2770-6. Nie K, Su MY, Chau MK, Chan S, Nguyen H, Tseng T, Huang Y, McLaren CE, Nalcioglu O, Chen JH. PMID: 20632587; PMCID: PMC2885945.
    View in: PubMed Mentions: 18 Fields:
    Translation:Humans
  22. A PIN diode controlled dual-tuned MRI RF coil and phased array for multi nuclear imaging. Phys Med Biol. 2010 May 07; 55(9):2589-600. Ha S, Hamamura MJ, Nalcioglu O, Muftuler LT. PMID: 20393229.
    View in: PubMed Mentions: 23 Fields:
  23. Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system. Opt Express. 2010 Apr 12; 18(8):7835-50. Lin Y, Barber WC, Iwanczyk JS, Roeck W, Nalcioglu O, Gulsen G. PMID: 20588625; PMCID: PMC2898749.
    View in: PubMed Mentions: 31 Fields:
  24. Development of a new RF coil and gamma-ray radiation shielding assembly for improved MR image quality in SPECT/MRI. Phys Med Biol. 2010 May 07; 55(9):2495-504. Ha S, Hamamura MJ, Roeck WW, Muftuler LT, Nalcioglu O. PMID: 20371909.
    View in: PubMed Mentions: 5 Fields:
    Translation:Animals
  25. Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology. 2010 Apr; 255(1):44-52. Chen JH, Nie K, Bahri S, Hsu CC, Hsu FT, Shih HN, Lin M, Nalcioglu O, Su MY. PMID: 20308443; PMCID: PMC2843830.
    View in: PubMed Mentions: 23 Fields:
    Translation:Humans
  26. Magnetic resonance imaging evaluation of noninflammatory breast cancer with skin involvement after neoadjuvant chemotherapy. Ann Surg Oncol. 2010 Jul; 17(7):1964-5. Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 20180030; PMCID: PMC2889290.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  27. Development of an MR-compatible SPECT system (MRSPECT) for simultaneous data acquisition. Phys Med Biol. 2010 Mar 21; 55(6):1563-75. Hamamura MJ, Ha S, Roeck WW, Muftuler LT, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 20164533.
    View in: PubMed Mentions: 16 Fields:
    Translation:Humans
  28. Foreword. Technol Cancer Res Treat. 2010 Feb; 9(1):1-4. Nalcioglu O, Su MY. PMID: 20082525; PMCID: PMC4232204.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimals
  29. Dual-contrast dynamic MRI-DOT for small animal imaging. Technol Cancer Res Treat. 2010 Feb; 9(1):61-70. Thayer D, Unlu MB, Lin Y, Yan K, Nalcioglu O, Gulsen G. PMID: 20082531; PMCID: PMC3961473.
    View in: PubMed Mentions: 7 Fields:
    Translation:Animals
  30. Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore. Technol Cancer Res Treat. 2010 Feb; 9(1):45-52. Barber WC, Lin Y, Nalcioglu O, Iwanczyk JS, Hartsough NE, Gulsen G. PMID: 20082529; PMCID: PMC2877036.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  31. Initial Investigation of preclinical integrated SPECT and MR imaging. Technol Cancer Res Treat. 2010 Feb; 9(1):21-8. Hamamura MJ, Ha S, Roeck WW, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 20082527; PMCID: PMC4235993.
    View in: PubMed Mentions: 4 Fields:
    Translation:Animals
  32. Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys. 2010 Jan; 37(1):217-26. Nie K, Chang D, Chen JH, Hsu CC, Nalcioglu O, Su MY. PMID: 20175484; PMCID: PMC2801737.
    View in: PubMed Mentions: 18 Fields:
    Translation:Humans
  33. Impact of skin removal on quantitative measurement of breast density using MRI. Med Phys. 2010 Jan; 37(1):227-33. Nie K, Chang D, Chen JH, Shih TC, Hsu CC, Nalcioglu O, Su MY. PMID: 20175485; PMCID: PMC2801738.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  34. Can proton MRS provide useful information for characterizing estrogen receptor status in breast cancer? Ann Oncol. 2010 Mar; 21(3):663-665. Baek HM, Chen JH, Nalcioglu O, Su MY. PMID: 19951954; PMCID: PMC2826101.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  35. Algorithm-based method for detection of blood vessels in breast MRI for development of computer-aided diagnosis. J Magn Reson Imaging. 2009 Oct; 30(4):817-24. Lin M, Chen JH, Nie K, Chang D, Nalcioglu O, Su MY. PMID: 19787727; PMCID: PMC2789993.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  36. Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol. 2010 Apr; 20(4):771-81. Newell D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY. PMID: 19789878; PMCID: PMC2835636.
    View in: PubMed Mentions: 53 Fields:
    Translation:Humans
  37. Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI. Ann Oncol. 2009 Aug; 20(8):1449-50. Chen JH, Chang D, Nie K, Hsu FT, Shih HN, Hsu CC, Nalcioglu O, Su MY. PMID: 19654205; PMCID: PMC2733064.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  38. Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol. 2009 Aug; 20(8):1447-9. Chen JH, Hsu FT, Shih HN, Hsu CC, Chang D, Nie K, Nalcioglu O, Su MY. PMID: 19654204; PMCID: PMC2720819.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  39. A variable torque motor compatible with magnetic resonance imaging. Rev Sci Instrum. 2009 Apr; 80(4):046108. Roeck WW, Ha SH, Farmaka S, Nalcioglu O. PMID: 19405704.
    View in: PubMed Mentions: 1 Fields:
  40. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer. 2009 Apr 01; 115(7):1363-80. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. PMID: 19197974; PMCID: PMC2748779.
    View in: PubMed Mentions: 37 Fields:
    Translation:Humans
  41. Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol. 2009 Jun; 16(6):1619-28. Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY. PMID: 19333654; PMCID: PMC2786305.
    View in: PubMed Mentions: 29 Fields:
    Translation:Humans
  42. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology. 2009 Jun; 251(3):653-62. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY. PMID: 19276320; PMCID: PMC2687529.
    View in: PubMed Mentions: 58 Fields:
    Translation:Humans
  43. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg. 2009 Mar; 249(3):448-54. Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY. PMID: 19247033; PMCID: PMC2789298.
    View in: PubMed Mentions: 16 Fields:
    Translation:Humans
  44. Quantitative fluorescence tomography with functional and structural a priori information. Appl Opt. 2009 Mar 01; 48(7):1328-36. Lin Y, Yan H, Nalcioglu O, Gulsen G. PMID: 19252634; PMCID: PMC2737514.
    View in: PubMed Mentions: 29 Fields:
  45. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol. 2008 Dec; 15(12):1513-25. Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY. PMID: 19000868; PMCID: PMC2791407.
    View in: PubMed Mentions: 104 Fields:
    Translation:Humans
  46. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Med Phys. 2008 Dec; 35(12):5253-62. Nie K, Chen JH, Chan S, Chau MK, Yu HJ, Bahri S, Tseng T, Nalcioglu O, Su MY. PMID: 19175084; PMCID: PMC2673600.
    View in: PubMed Mentions: 83 Fields:
    Translation:Humans
  47. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 2008 Dec; 28(6):1499-505. Chen JH, Nalcioglu O, Su MY. PMID: 19025938; PMCID: PMC2597344.
    View in: PubMed Mentions: 14 Fields:
    Translation:Humans
  48. Simultaneous in vivo dynamic magnetic resonance-diffuse optical tomography for small animal imaging. J Biomed Opt. 2008 Nov-Dec; 13(6):060501. Unlu MB, Lin Y, Birgul O, Nalcioglu O, Gulsen G. PMID: 19123642; PMCID: PMC2943837.
    View in: PubMed Mentions: 9 Fields:
    Translation:Animals
  49. Cognitive dysfunction after experimental febrile seizures. Exp Neurol. 2009 Jan; 215(1):167-77. Dubé CM, Zhou JL, Hamamura M, Zhao Q, Ring A, Abrahams J, McIntyre K, Nalcioglu O, Shatskih T, Baram TZ, Holmes GL. PMID: 19000675; PMCID: PMC2649663.
    View in: PubMed Mentions: 63 Fields:
    Translation:AnimalsCells
  50. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann Surg Oncol. 2008 Dec; 15(12):3609-13. Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 18807091; PMCID: PMC2613188.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  51. Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers? Int J Cancer. 2008 Sep 01; 123(5):1219-21. Baek HM, Chen JH, Nalcioglu O, Su MY. PMID: 18546272; PMCID: PMC2613431.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  52. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol. 2008 Jul; 82(14):7078-88. Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H, Cantin EM. PMID: 18480436; PMCID: PMC2446972.
    View in: PubMed Mentions: 85 Fields:
    Translation:AnimalsCells
  53. Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging. 2008 May; 27(5):1114-21. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY. PMID: 18425841; PMCID: PMC2613433.
    View in: PubMed Mentions: 16 Fields:
    Translation:Humans
  54. Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging. 2008 Nov; 26(9):1207-14. Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. PMID: 18436406; PMCID: PMC2613187.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  55. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging. 2008 Apr; 27(4):825-33. Chen JH, Baek HM, Nalcioglu O, Su MY. PMID: 18383260; PMCID: PMC2613434.
    View in: PubMed Mentions: 19 Fields:
    Translation:Humans
  56. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter? Ann Oncol. 2008 May; 19(5):1024-6. Chen JH, Nalcioglu O, Su MY. PMID: 18375524; PMCID: PMC2613432.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  57. Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol. 2008 May; 19(5):1022-4. Baek HM, Chen JH, Nalcioglu O, Su MY. PMID: 18372283; PMCID: PMC2613189.
    View in: PubMed Mentions: 20 Fields:
    Translation:Humans
  58. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol. 2008 Apr; 19(4):822-4. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. PMID: 18325916; PMCID: PMC2613186.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  59. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008 Jan 01; 112(1):17-26. Chen JH, Feig B, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. PMID: 18000804.
    View in: PubMed Mentions: 57 Fields:
    Translation:HumansCTClinical Trials
  60. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy. J Clin Oncol. 2007 Dec 10; 25(35):5667-9. Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. PMID: 18065744.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  61. Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging. 2008 May; 26(4):523-31. Baek HM, Yu HJ, Chen JH, Nalcioglu O, Su MY. PMID: 18060716; PMCID: PMC2653063.
    View in: PubMed Mentions: 19 Fields:
    Translation:HumansCells
  62. Triple-negative breast cancer: MRI features in 29 patients. Ann Oncol. 2007 Dec; 18(12):2042-3. Chen JH, Agrawal G, Feig B, Baek HM, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. PMID: 18029970.
    View in: PubMed Mentions: 29 Fields:
    Translation:Humans
  63. Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers. Ann Surg Oncol. 2008 Mar; 15(3):941-2. Chen JH, Agrawal G, Carpenter P, Mehta RS, Nalcioglu O, Su MY. PMID: 18004624.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  64. MRI features of breast cancer: a correlation study with HER-2 receptor. Ann Oncol. 2007 Nov; 18(11):1903-4. Agrawal G, Chen JH, Baek HM, Hsiang D, Mehta RS, Nalcioglu O, Su MY. PMID: 17993631.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  65. Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study. Phys Med Biol. 2007 Sep 21; 52(18):5569-85. Lin Y, Gao H, Nalcioglu O, Gulsen G. PMID: 17804882.
    View in: PubMed Mentions: 29 Fields:
  66. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging. 2007 Sep; 26(3):615-23. Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 17729334.
    View in: PubMed Mentions: 43 Fields:
    Translation:Humans
  67. In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol. 2007 Jul 24; 7:12. Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ. PMID: 17650332; PMCID: PMC1945027.
    View in: PubMed Mentions: 17 Fields:
    Translation:Animals
  68. Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol. 2007 Jun 20; 25(18):2618-20. Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. PMID: 17577043.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  69. Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma. 2007 Apr; 24(4):674-89. Nishi RA, Liu H, Chu Y, Hamamura M, Su MY, Nalcioglu O, Anderson AJ. PMID: 17439350.
    View in: PubMed Mentions: 44 Fields:
    Translation:Animals
  70. An optimization method for designing SENSE imaging RF coil arrays. J Magn Reson. 2007 Jun; 186(2):273-81. Chen G, Muftuler LT, Ha SH, Nalcioglu O. PMID: 17428711.
    View in: PubMed Mentions: 2 Fields:
  71. An inverse method to design RF coil arrays optimized for SENSE imaging. Phys Med Biol. 2006 Dec 21; 51(24):6457-69. Muftuler LT, Chen G, Nalcioglu O. PMID: 17148829.
    View in: PubMed Mentions: 5 Fields:
  72. Contrast and spatial resolution in MREIT using low amplitude current. Phys Med Biol. 2006 Oct 07; 51(19):5035-49. Birgul O, Hamamura MJ, Muftuler LT, Nalcioglu O. PMID: 16985286.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  73. Diffuse optical tomographic reconstruction using multifrequency data. J Biomed Opt. 2006 Sep-Oct; 11(5):054008. Burcin Unlu M, Birgul O, Shafiiha R, Gulsen G, Nalcioglu O. PMID: 17092157.
    View in: PubMed Mentions: 10 Fields:
  74. Resolution improvement in positron emission tomography using anatomical Magnetic Resonance Imaging. Technol Cancer Res Treat. 2006 Aug; 5(4):311-7. Chu Y, Su MY, Mandelkern M, Nalcioglu O. PMID: 16866561.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  75. Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat. 2006 Aug; 5(4):351-63. Gulsen G, Birgul O, Unlu MB, Shafiiha R, Nalcioglu O. PMID: 16866566.
    View in: PubMed Mentions: 30 Fields:
    Translation:Animals
  76. In vivo MRI electrical impedance tomography (MREIT) of tumors. Technol Cancer Res Treat. 2006 Aug; 5(4):381-7. Muftuler LT, Hamamura MJ, Birgul O, Nalcioglu O. PMID: 16866568.
    View in: PubMed Mentions: 14 Fields:
    Translation:Animals
  77. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat. 2006 Aug; 5(4):401-10. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. PMID: 16866570.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  78. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA. 2006 May; 19(2):96-104. Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. PMID: 16779565.
    View in: PubMed Mentions: 40 Fields:
    Translation:Humans
  79. Measurement of ion diffusion using magnetic resonance electrical impedance tomography. Phys Med Biol. 2006 Jun 07; 51(11):2753-62. Hamamura MJ, Muftuler LT, Birgul O, Nalcioglu O. PMID: 16723764.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansCells
  80. Design and implementation of a multifrequency near-infrared diffuse optical tomography system. J Biomed Opt. 2006 Jan-Feb; 11(1):014020. Gulsen G, Xiong B, Birgul O, Nalcioglu O. PMID: 16526897.
    View in: PubMed Mentions: 18 Fields:
  81. Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat. 2005 Oct; 4(5):549-58. Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B. PMID: 16173825.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  82. Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients. Technol Cancer Res Treat. 2005 Jun; 4(3):255-63. Su MY, Yu HJ, Carpenter PM, McLaren CE, Nalcioglu O. PMID: 15896081.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  83. Resolution and contrast in magnetic resonance electrical impedance tomography (MREIT) and its application to cancer imaging. Technol Cancer Res Treat. 2004 Dec; 3(6):599-609. Muftuler LT, Hamamura M, Birgul O, Nalcioglu O. PMID: 15560718.
    View in: PubMed Mentions: 8 Fields:
    Translation:Animals
  84. Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death. Ann Neurol. 2004 Nov; 56(5):709-14. Dubé C, Yu H, Nalcioglu O, Baram TZ. PMID: 15389889; PMCID: PMC3084032.
    View in: PubMed Mentions: 33 Fields:
    Translation:AnimalsCells
  85. Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol. 2004 Aug; 165(2):449-56. Samoszuk M, Deng T, Hamamura MJ, Su MY, Asbrock N, Nalcioglu O. PMID: 15277219; PMCID: PMC1618560.
    View in: PubMed Mentions: 5 Fields:
    Translation:AnimalsCells
  86. Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat. 2003 Dec; 2(6):563-9. Merritt S, Gulsen G, Chiou G, Chu Y, Deng C, Cerussi AE, Durkin AJ, Tromberg BJ, Nalcioglu O. PMID: 14640767.
    View in: PubMed Mentions: 35 Fields:
  87. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging. 2003 Oct; 18(4):467-77. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL. PMID: 14508784.
    View in: PubMed Mentions: 50 Fields:
    Translation:Humans
  88. Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin. Thromb Haemost. 2003 Aug; 90(2):351-60. Samoszuk M, Corwin M, Yu H, Wang J, Nalcioglu O, Su MY. PMID: 12888884.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansAnimalsCells
  89. Coregistration of diffuse optical spectroscopy and magnetic resonance imaging in a rat tumor model. Appl Opt. 2003 Jun 01; 42(16):2951-9. Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ, Gulsen G, Yu H, Wang J, Nalcioglu O. PMID: 12790444.
    View in: PubMed Mentions: 3 Fields:
    Translation:Animals
  90. In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. Appl Opt. 2003 Jun 01; 42(16):2940-50. Cuccia DJ, Bevilacqua F, Durkin AJ, Merritt S, Tromberg BJ, Gulsen G, Yu H, Wang J, Nalcioglu O. PMID: 12790443.
    View in: PubMed Mentions: 27 Fields:
    Translation:Animals
  91. A simple simultaneous geometric and intensity correction method for echo-planar imaging by EPI-based phase modulation. IEEE Trans Med Imaging. 2003 Feb; 22(2):200-5. Chiou JY, Ahn CB, Muftuler LT, Nalcioglu O. PMID: 12715996.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  92. Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring. Technol Cancer Res Treat. 2002 Dec; 1(6):479-88. Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. PMID: 12625775.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimals
  93. Congruent MRI and near-infrared spectroscopy for functional and structural imaging of tumors. Technol Cancer Res Treat. 2002 Dec; 1(6):497-505. Gulsen G, Yu H, Wang J, Nalcioglu O, Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ. PMID: 12625777.
    View in: PubMed Mentions: 7 Fields:
    Translation:Animals
  94. A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging. Radiat Res. 2002 Aug; 158(2):152-8. Yu H, Su MY, Wang Z, Nalcioglu O. PMID: 12105984.
    View in: PubMed Mentions: 3 Fields:
    Translation:HumansAnimals
  95. A double end-cap birdcage RF coil for small animal whole body imaging. J Magn Reson. 2002 Jun; 156(2):309-12. Gulsen G, Muftuler LT, Nalcioglu O. PMID: 12165267.
    View in: PubMed Mentions: 4 Fields:
    Translation:Animals
  96. Assessment of protamine-induced thrombosis of tumor vessels for cancer therapy using dynamic contrast-enhanced MRI. NMR Biomed. 2002 Apr; 15(2):106-13. Su MY, Samoszuk MK, Wang J, Nalcioglu O. PMID: 11870906.
    View in: PubMed Mentions: 4 Fields:
    Translation:Animals
  97. Automatic tuned MRI RF coil for multinuclear imaging of small animals at 3T. J Magn Reson. 2002 Mar; 155(1):39-44. Muftuler LT, Gulsen G, Sezen KD, Nalcioglu O. PMID: 11945031.
    View in: PubMed Mentions: 12 Fields:
    Translation:Animals
  98. Measuring microvascular density in tumors by digital dissection. Anal Quant Cytol Histol. 2002 Feb; 24(1):15-22. Samoszuk M, Leonor L, Espinoza F, Carpenter PM, Nalcioglu O, Su MY. PMID: 11865945.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansAnimals
  99. Applications of dynamic contrast enhanced MRI in oncology: measurement of tumor oxygen tension. Technol Cancer Res Treat. 2002 Feb; 1(1):29-38. Wang Z, Su MY, Nalcioglu O. PMID: 12614174.
    View in: PubMed Mentions: 7 Fields:
    Translation:Animals
  100. FMRI study relevant to the Mozart effect: brain areas involved in spatial-temporal reasoning. Neurol Res. 2001 Oct; 23(7):683-90. Bodner M, Muftuler LT, Nalcioglu O, Shaw GL. PMID: 11680506.
    View in: PubMed Mentions: 15 Fields:
    Translation:Humans
  101. Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI. Magn Reson Imaging. 2001 Oct; 19(8):1063-72. Wang Z, Su MY, Najafi A, Nalcioglu O. PMID: 11711230.
    View in: PubMed Mentions: 10 Fields:
    Translation:Animals
  102. Selective thrombosis of tumor blood vessels in mammary adenocarcinoma implants in rats. Am J Pathol. 2001 Jul; 159(1):245-51. Samoszuk MK, Su MY, Najafi A, Nalcioglu O. PMID: 11438471; PMCID: PMC1850411.
    View in: PubMed Mentions: Fields:
    Translation:Animals
  103. Improvement of temporal resolution in fMRI using slice phase encode reordered 3D EPI. Magn Reson Med. 2000 Sep; 44(3):485-90. Muftuler LT, Nalcioglu O. PMID: 10975903.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansCTClinical Trials
  104. Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magn Reson Imaging. 2000 Apr; 18(3):311-7. Su MY, Taylor JA, Villarreal LP, Nalcioglu O. PMID: 10745141.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansAnimalsCells
  105. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000 Jan-Apr; 2(1-2):152-65. Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. PMID: 10933074; PMCID: PMC1531871.
    View in: PubMed Mentions: 44 Fields:
    Translation:HumansAnimals
  106. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging. 1999 Feb; 9(2):177-86. Su MY, Wang Z, Carpenter PM, Lao X, Mühler A, Nalcioglu O. PMID: 10077011.
    View in: PubMed Mentions: 13 Fields:
    Translation:Animals
  107. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. J Magn Reson Imaging. 1999 Jan; 9(1):128-37. Su MY, Wang Z, Nalcioglu O. PMID: 10030660.
    View in: PubMed Mentions: 3 Fields:
    Translation:Animals
  108. Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol Aging. 1998 Sep-Oct; 19(5):479-85. Su MY, Head E, Brooks WM, Wang Z, Muggenburg BA, Adam GE, Sutherland R, Cotman CW, Nalcioglu O. PMID: 9880050.
    View in: PubMed Mentions: 47 Fields:
    Translation:HumansAnimals
  109. Measurement of tumor vascular volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-albumin enhanced and diffusion-weighted MRI. Magn Reson Med. 1998 Sep; 40(3):397-404. Wang Z, Su MY, Nalcioglu O. PMID: 9727942.
    View in: PubMed Mentions: 4 Fields:
    Translation:Animals
  110. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med. 1998 Feb; 39(2):259-69. Su MY, Mühler A, Lao X, Nalcioglu O. PMID: 9469709.
    View in: PubMed Mentions: 28 Fields:
    Translation:HumansAnimals
  111. An FEM approach for the characterization of the RF field homogeneity at high field. Magn Reson Med. 1997 Jan; 37(1):76-83. Guclu C, Kashmar G, Hacinliyan A, Nalcioglu O. PMID: 8978635.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  112. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med. 1996 Dec; 36(6):868-77. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, Nalcioglu O. PMID: 8946352.
    View in: PubMed Mentions: 5 Fields:
    Translation:Animals
  113. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med. 1995 Sep; 34(3):402-11. Su MY, Najafi AA, Nalcioglu O. PMID: 7500880.
    View in: PubMed Mentions: 9 Fields:
    Translation:Animals
  114. Homonuclear J-refocused spectral editing technique for quantification of glutamine and glutamate by 1H NMR spectroscopy. Magn Reson Med. 1995 Aug; 34(2):253-9. Lee HK, Yaman A, Nalcioglu O. PMID: 7476085.
    View in: PubMed Mentions: 11 Fields:
  115. Data analysis for dynamic contrast-enhanced MRI-based cerebral perfusion measurements: correcting for changing cortical CSF volumes. MAGMA. 1995 Mar; 3(1):41-8. Emerson JF, Chen PC, Shankle WR, Haier RJ, Nalcioglu O. PMID: 7600175.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  116. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med. 1994 Dec; 32(6):714-24. Su MY, Jao JC, Nalcioglu O. PMID: 7869893.
    View in: PubMed Mentions: 15 Fields:
    Translation:Animals
  117. Cortical CSF volume fluctuations by MRI in brain aging, dementia and hydrocephalus. Neuroreport. 1994 Sep 08; 5(14):1699-704. Emerson JF, Chen PC, Shankle WR, Greensite FS, Foltz EL, Lott IT, Nalcioglu O. PMID: 7827311.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansCTClinical Trials
  118. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology. 1994 Jun; 44(6):1039-45. Kesslak JP, Nagata SF, Lott I, Nalcioglu O. PMID: 8208396.
    View in: PubMed Mentions: 41 Fields:
    Translation:Humans
  119. Monitoring of pO2 by spin-spin relaxation rate 1/T2 of 19F in a rabbit abscess model. Artif Cells Blood Substit Immobil Biotechnol. 1994; 22(4):1449-54. Guo Q, Mattrey RF, Guclu C, Buxton RB, Nalcioglu O. PMID: 7849956.
    View in: PubMed Mentions: 6 Fields:
    Translation:Animals
  120. Statistical description of microcirculatory flow as measured with an MR method. J Magn Reson Imaging. 1993 Nov-Dec; 3(6):883-7. Su MY, Nalcioglu O. PMID: 8280978.
    View in: PubMed Mentions: Fields:
  121. Susceptibility effects in porous media in the presence of flow. J Magn Reson Imaging. 1993 Sep-Oct; 3(5):794-9. Su MY, Nalcioglu O. PMID: 8400567.
    View in: PubMed Mentions: Fields:
  122. Flow field mapping by multi-zone adiabatic passage excitation. Magn Reson Imaging. 1993; 11(8):1129-37. Vu AT, Lee HK, Moran PR, Nalcioglu O. PMID: 8271899.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  123. Reduced-bandwidth method for F-19 imaging of perflubron. J Magn Reson Imaging. 1992 Sep-Oct; 2(5):563-8. Lee HK, Nalcioglu O. PMID: 1392249.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  124. Correction of chemical-shift artifacts in multislice F-19 imaging with perfluorooctyl bromide. Magn Reson Med. 1992 Feb; 23(2):324-32. Ozdemirel B, Nalcioglu O. PMID: 1549046.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  125. Correction of chemical-shift artifacts in 19F imaging of PFOB: a robust signed magnitude method. Magn Reson Med. 1992 Feb; 23(2):254-63. Lee HK, Nalcioglu O, Buxton RB. PMID: 1549040.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  126. Reblurred deconvolution method for chemical shift removal in F-19 (PFOB) MR imaging. J Magn Reson Imaging. 1992 Jan-Feb; 2(1):53-61. Lee HK, Nalcioglu O. PMID: 1623281.
    View in: PubMed Mentions: 4 Fields:
  127. Measurement of three-dimensional radiation dose distributions using MRI. Radiat Res. 1991 Oct; 128(1):1-13. Prasad PV, Nalcioglu O, Rabbani B. PMID: 1924718.
    View in: PubMed Mentions: 2 Fields:
  128. Correction for chemical-shift artifacts in 19F imaging of PFOB: simultaneous multislice imaging. Magn Reson Med. 1991 Sep; 21(1):21-9. Lee HK, Nalcioglu O, Buxton RB. PMID: 1943676.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  129. A modified pulse sequence for in vivo diffusion imaging with reduced motion artifacts. Magn Reson Med. 1991 Mar; 18(1):116-31. Prasad PV, Nalcioglu O. PMID: 2062224.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  130. Absolute cross-sectional area measurements in quantitative coronary arteriography by dual-energy DSA. Invest Radiol. 1991 Feb; 26(2):119-27. Molloi SY, Ersahin A, Roeck WW, Nalcioglu O. PMID: 2055711.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansAnimals
  131. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 1991 Jan; 41(1):51-4. Kesslak JP, Nalcioglu O, Cotman CW. PMID: 1985296.
    View in: PubMed Mentions: 97 Fields:
    Translation:Humans
  132. Cartesian echo planar hybrid scanning with two to eight echoes. IEEE Trans Med Imaging. 1991; 10(1):1-10. Kashmar G, Nalcioglu O. PMID: 18222795.
    View in: PubMed Mentions: Fields:
  133. Spatially resolved flow velocity measurements and projection angiography by adiabatic passage. Magn Reson Imaging. 1991; 9(1):115-27. Lee HK, Nalcioglu O, Moran PR. PMID: 2056849.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  134. NMR angiography with enhanced quasi-half-echo scanning. Magn Reson Imaging. 1991; 9(2):129-39. Guo Q, Kashmar G, Nalcioglu O. PMID: 2034045.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  135. Projection images of the position-velocity joint spin density distribution. Magn Reson Med. 1990 Jul; 15(1):112-20. Xiang QS, Nalcioglu O. PMID: 2374491.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  136. Investigation of blood flow dynamics by NMR angiography. Magn Reson Imaging. 1990; 8(2):167-72. Guo Q, Friloux L, Nalcioglu O. PMID: 2338897.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  137. Differential flow imaging by NMR. Magn Reson Med. 1989 Oct; 12(1):14-24. Xiang QS, Nalcioglu O. PMID: 2607957.
    View in: PubMed Mentions: Fields:
  138. Correlation of minimum coronary lumen diameter with left ventricular functional impairment induced by atrial pacing. Am J Cardiol. 1988 Apr 01; 61(10):697-703. Tobis J, Sato D, Nalcioglu O, Johnston WD, Mallery J, See J, Qu L, Reese T, Paynter J, Montelli S, et al. PMID: 3354432.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  139. Measurement of mean and variance of velocity fields within each voxel by NMR imaging. IEEE Trans Med Imaging. 1988; 7(4):364-7. Xiang QS, Nalcioglu O. PMID: 18230490.
    View in: PubMed Mentions: Fields:
  140. Methods and algorithms for Fourier-transform nuclear magnetic resonance tomography. J Opt Soc Am A. 1987 May; 4(5):923-32. Cho ZH, Nalcioglu O, Park HW. PMID: 3598744.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansAnimals
  141. Measurement of bulk and random directional velocity fields by NMR imaging. IEEE Trans Med Imaging. 1987; 6(4):356-9. Nalcioglu O, Cho ZH. PMID: 18244045.
    View in: PubMed Mentions: 1 Fields:
  142. Videodensitometric determination of minimum coronary artery luminal diameter before and after angioplasty. Am J Cardiol. 1987 Jan 01; 59(1):38-44. Tobis J, Nalcioglu O, Johnston WD, Qu L, Reese T, Sato D, Roeck W, Montelli S, Henry WL. PMID: 2949580.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  143. The effects of random directional distributed flow in nuclear magnetic resonance imaging. Med Phys. 1987 Jan-Feb; 14(1):43-8. Ahn CB, Lee SY, Nalcioglu O, Cho ZH. PMID: 3561335.
    View in: PubMed Mentions: 17 Fields:
    Translation:HumansCells
  144. A fonnalism for generating multiparametric encoding gradients in NMR tomography. IEEE Trans Med Imaging. 1987; 6(1):14-20. Xiang QS, Nalcioglu O. PMID: 18230422.
    View in: PubMed Mentions: Fields:
  145. An improved nuclear magnetic resonance diffusion coefficient imaging method using an optimized pulse sequence. Med Phys. 1986 Nov-Dec; 13(6):789-93. Ahn CB, Lee SY, Nalcioglu O, Cho ZH. PMID: 3796474.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  146. Digital angiography: the implementation of computer technology for cardiovascular imaging. Prog Cardiovasc Dis. 1985 Nov-Dec; 28(3):195-212. Tobis J, Nalcioglu O, Henry W. PMID: 3903864.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  147. Determination of the optimal timing for performing digital ventriculography during atrial pacing stress tests in coronary heart disease. Am J Cardiol. 1985 Sep 01; 56(7):426-33. Tobis J, Iseri L, Johnston WD, Nalcioglu O, De Boer C, Shah A, Paynter J, Henry WL. PMID: 3898797.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  148. Digital coronary roadmapping as an aid for performing coronary angioplasty. Am J Cardiol. 1985 Aug 01; 56(4):237-41. Tobis J, Johnston WD, Montelli S, Henderson E, Roeck W, Bauer B, Nalcioglu O, Henry W. PMID: 3161319.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  149. Chemical-shift artifact correction scheme using echo-time encoding technique. Magn Reson Med. 1985 Jun; 2(3):253-61. Cho ZH, Nalcioglu O, Park HW, Ra JB, Hilal SK. PMID: 3831694.
    View in: PubMed Mentions: 2 Fields:
  150. Removal of image intensifier veiling glare by mathematical deconvolution techniques. Med Phys. 1985 May-Jun; 12(3):281-8. Seibert JA, Nalcioglu O, Roeck W. PMID: 4010632.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansAnimalsCells
  151. Constrained iterative reconstruction by the conjugate gradient method. IEEE Trans Med Imaging. 1985; 4(2):65-71. Kawata S, Nalcioglu O. PMID: 18243953.
    View in: PubMed Mentions: 5 Fields:
  152. On the relationship of image intensifier contrast ratios measured by two techniques. Phys Med Biol. 1984 Oct; 29(10):1231-6. Nalcioglu O, Roeck WW, Lando AV, Seibert JA. PMID: 6494249.
    View in: PubMed Mentions: Fields:
  153. Detection and quantitation of coronary artery stenoses from digital subtraction angiograms compared with 35-millimeter film cineangiograms. Am J Cardiol. 1984 Sep 01; 54(6):489-96. Tobis J, Nalcioglu O, Iseri L, Johnston WD, Roeck W, Castleman E, Bauer B, Montelli S, Henry WL. PMID: 6383001.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  154. Limits to signal-to-noise improvement by FID averaging in NMR imaging. Phys Med Biol. 1984 Aug; 29(8):969-78. Nalcioglu O, Cho ZH. PMID: 6483968.
    View in: PubMed Mentions: 3 Fields:
  155. Characterization of the veiling glare PSF in x-ray image intensified fluoroscopy. Med Phys. 1984 Mar-Apr; 11(2):172-9. Seibert JA, Nalcioglu O, Roeck WW. PMID: 6727792.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  156. Measurement of left ventricular ejection fraction by videodensitometric analysis of digital subtraction angiograms. Am J Cardiol. 1983 Oct 01; 52(7):871-5. Tobis J, Nalcioglu O, Seibert A, Johnston WD, Henry WL. PMID: 6353899.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  157. Digital subtraction angiography. Chest. 1983 Jul; 84(1):68-75. Tobis JM, Nalcioglu O, Henry WL. PMID: 6345103.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansPHPublic Health
  158. Correlation of 10-milliliter digital subtraction ventriculograms compared with standard cineangiograms. Am Heart J. 1983 Jun; 105(6):946-52. Tobis JM, Nalcioglu O, Johnston WD, Seibert A, Roeck W, Iseri LT, Elkayam U, Henry WL. PMID: 6344605.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  159. Digital angiography in assessment of ventricular function and wall motion during pacing in patients with coronary artery disease. Am J Cardiol. 1983 Mar 01; 51(5):668-75. Tobis J, Nalcioglu O, Johnston WD, Seibert A, Iseri LT, Roeck W, Henry WL. PMID: 6338687.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  160. Normalization (division) versus subtraction of digitized images. Med Phys. 1983 Jan-Feb; 10(1):25-8. Baily NA, Rimkus D, Nalcioglu O. PMID: 6341800.
    View in: PubMed Mentions: 1 Fields:
  161. Undersampling Errors in Region-of-Interest Tomography. IEEE Trans Med Imaging. 1982; 1(3):168-73. Sankar PV, Nalcioglu O, Sklansky J. PMID: 18238271.
    View in: PubMed Mentions: 2 Fields:
  162. A method for dose determination in computerized tomography. Health Phys. 1979 Oct; 37(4):543-8. Yalcintas MG, Nalcioglu O. PMID: 536216.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansPHPublic Health
  163. Post-reconstruction method for beam hardening in computerised tomography. Phys Med Biol. 1979 Mar; 24(2):330-40. Nalcioglu O, Lou RY. PMID: 450974.
    View in: PubMed Mentions: 9 Fields:

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs